Publications by authors named "Solange Peters"

100Publications

Survey of the Impact of COVID-19 on Oncologists' Decision Making in Cancer.

JCO Glob Oncol 2020 08;6:1248-1257

Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/GO.20.00300DOI Listing
August 2020

Gender gap: surveying the world for tomorrow.

ESMO Open 2020 Jul;5(4)

Oncology Department, CHUV, Lausanne, VD, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2020-000805DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342817PMC
July 2020

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.

Lancet 2020 06 28;395(10241):1907-1918. Epub 2020 May 28.

Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(20)31187-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255743PMC
June 2020

[Small-cell lung cancer: management and novelties].

Rev Med Suisse 2020 May;16(695):1079-1085

Service d'oncologie médicale, Département d'oncologie, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source
May 2020

Une période de craintes et de défis : vers un monde meilleur ?

Rev Med Suisse 2020 May;16(695):1071-1072

Département d'oncologie, CHUV, Lausanne.

View Article

Download full-text PDF

Source
May 2020

The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer.

Cancer Cell 2020 06 29;37(6):738-741. Epub 2020 Apr 29.

Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2020.04.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188629PMC
June 2020

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.

Cancer Cell 2020 06 16;37(6):742-745. Epub 2020 May 16.

Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2020.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229923PMC
June 2020

[Oncology: navigating the COVID-19 Pandemic and Steer the Course].

Rev Med Suisse 2020 Apr;16(N° 691-2):819-822

Service d'oncologie médicale, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source
April 2020

Challenges in lung cancer therapy during the COVID-19 pandemic.

Lancet Respir Med 2020 06 9;8(6):542-544. Epub 2020 Apr 9.

Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy; NIBIT Foundation Onlus, Siena, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(20)30170-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146673PMC
June 2020

Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study.

ERJ Open Res 2020 Jan 16;6(1). Epub 2020 Mar 16.

Dept of Radiodiagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/23120541.00165-2019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073419PMC
January 2020

Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement.

Lung Cancer 2020 Apr 1;142:114-119. Epub 2020 Feb 1.

Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany; German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2020.01.019DOI Listing
April 2020

Journée du cancer : mobiliser autour de la prévention.

Rev Med Suisse 2020 Feb;16(682):382-383

Chef du centre d'oncologie Département d'oncologie HUG, Genève.

View Article

Download full-text PDF

Source
February 2020

Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?

Lancet Oncol 2020 03 3;21(3):320-322. Epub 2020 Feb 3.

Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne University, CH-1011 Lausanne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30859-9DOI Listing
March 2020

Development and implementation strategies of a nurse-led symptom self-management program in outpatient cancer centres: The Symptom Navi© Programme.

Eur J Oncol Nurs 2020 Feb 20;44:101714. Epub 2019 Dec 20.

Institute of Higher Education and Research in Health Care IUFRS, Faculty of Biology and Medicine, University of Lausanne and Lausanne University Hospital, SV-A Secteur Vennes, Route de la Corniche 10, CH-1010, Lausanne, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Rue du Bugnon 21, CH-1011, Lausanne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2019.101714DOI Listing
February 2020

Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.

J Immunother Cancer 2019 12 2;7(1):336. Epub 2019 Dec 2.

Department of Medical Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0818-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889661PMC
December 2019

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

N Engl J Med 2019 11 28;381(21):2020-2031. Epub 2019 Sep 28.

From the Memorial Sloan Kettering Cancer Center, New York (M.D.H.); Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas, Universidad Complutense, and Centro de Investigación Biomédica en Red de Cáncer, Madrid (L.P.-A.), Hospital Universitario Virgen Del Rocio, Seville (R.B.C.), and the Catalan Institute of Oncology-Germans Trias i Pujol Hospital, Badalona (E.C.C.) - all in Spain; Ambulatorium Chemioterapii, Bydgoszcz, Poland (B.Z.); the Asan Medical Center (S.-W.K.) and the Samsung Medical Center at Sungkyunkwan University School of Medicine (K.P.) - both in Seoul, South Korea; the Institute of Oncology Prof. Dr. Alexandru Trestioreanu, Bucharest, Romania (A.A.); the Hospital Italiano de Buenos Aires, Buenos Aires (L.L.); Instituto Jalisciense de Cancerologia, Guadalajara, Mexico (E.M.J.); the Saitama Cancer Center, Saitama, Japan (H.S.); Matrai Gyogyintezet, Matrahaza, Hungary (I.A.); Limoges University Hospital, Limoges (A.V.), and Aix-Marseille University, National Center for Scientific Research, INSERM, Centre de Recherche en Cancérologie de Marseille, Assistance Publique-Hôpitaux de Marseille, Marseille (F.B.) - all in France; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland (S.P.); Sotiria General Hospital, National and Kapodistrian University of Athens, Athens (K.S.); Lung Clinic Grosshansdorf, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany (M.R.); Fox Chase Cancer Center, Philadelphia (H.B.); Johns Hopkins Kimmel Cancer Center, Baltimore (J.R.B.); Princess Alexandra Hospital, Brisbane, QLD, Australia (K.J.O.); Bristol-Myers Squibb, Princeton, NJ (W.J.G., P.B., S.K.R., R.S.K., F.E.N.); and Winship Cancer Institute, Emory University, Atlanta (S.S.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1910231DOI Listing
November 2019

Appraising the Tail of the Survival Curve in the Era of PD-1/PD-L1 Checkpoint Blockade.

JAMA Oncol 2019 Jul 25. Epub 2019 Jul 25.

Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2019.2186DOI Listing
July 2019

Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis.

Lung Cancer 2019 08 30;134:127-140. Epub 2019 May 30.

Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.029DOI Listing
August 2019

Preanalytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis.

J Mol Diagn 2019 09 25;21(5):756-767. Epub 2019 Jun 25.

University of Vermont Health Network, Larner College of Medicine at the University of Vermont, Burlington, Vermont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2019.05.004DOI Listing
September 2019

F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer.

Eur J Nucl Med Mol Imaging 2019 Aug 18;46(9):1859-1868. Epub 2019 Jun 18.

Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Rue du Bugnon 46, CH-1011, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-019-04348-xDOI Listing
August 2019

[The new management options for lung cancer in the immunotherapy era].

Rev Med Suisse 2019 May;15(651):1032-1037

Direction oncologie médicale, CHUV, BH 07, 1011 Lausanne.

View Article

Download full-text PDF

Source
May 2019

De sérieuses préoccupations qui ne cachent pas nos espoirs.

Rev Med Suisse 2019 May;15(651):999-1000

Département d'oncologie, HUG, Genève.

View Article

Download full-text PDF

Source
May 2019

Brain metastases.

Nat Rev Dis Primers 2019 01 17;5(1). Epub 2019 Jan 17.

Department of Neurosurgery, University of California-Davis, School of Medicine, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41572-018-0055-y
Publisher Site
http://dx.doi.org/10.1038/s41572-018-0055-yDOI Listing
January 2019

Immunotherapy for the First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer.

Clin Cancer Res 2019 05 14;25(9):2691-2698. Epub 2019 Jan 14.

Research & Development, MedImmune, Gaithersburg, Maryland.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-3904DOI Listing
May 2019

[Oncology, what's new in 2018].

Rev Med Suisse 2019 Jan;15(N° 632-633):78-81

Service d'oncologie médicale, Département d'oncologie, CHUV, 1011 Lausanne.

View Article

Download full-text PDF

Source
January 2019

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.

Lancet Oncol 2019 01;20(1):e54-e64

Service Immunologie et Allergie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Centre d'Immunothérapie et de Vaccinologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Faculté Médecine Paris Descartes, Université Paris Descartes, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045183082
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(18)30828-3DOI Listing
January 2019

Characterisation of rare haematological immune-related toxicities.

Lancet Haematol 2019 01 4;6(1):e10-e11. Epub 2018 Dec 4.

Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(18)30180-7DOI Listing
January 2019

Immune Checkpoint Inhibitors in the Management of Lung Cancer.

Am Soc Clin Oncol Educ Book 2018 May;38:682-695

From the Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA; and the Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_201319DOI Listing
May 2018

Delineating the Role of PD-1/PD-L1 Blockade in Advanced SCLC.

J Thorac Oncol 2018 09;13(9):1242-1244

Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183077
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.05.042DOI Listing
September 2018

Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation-Positive Advanced NSCLC: Findings From a Global Named Patient Use Program.

J Thorac Oncol 2018 12 7;13(12):1897-1905. Epub 2018 Aug 7.

Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.07.093DOI Listing
December 2018

Acceptance of the Advanced Practice Nurse in Lung Cancer Role by Healthcare Professionals and Patients: A Qualitative Exploration.

J Nurs Scholarsh 2018 09 22;50(5):540-548. Epub 2018 Jul 22.

Institute of Higher Education and Research in Healthcare, Faculty of Biology and Medicine, University of Lausanne, and Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jnu.12411DOI Listing
September 2018

Management of Resistance to First-Line Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor Therapy.

Curr Treat Options Oncol 2018 05 28;19(7):37. Epub 2018 May 28.

Oncology Department, Centre Hospitalier Universitaire Vaudois, BH09/725, Rue du Bugnon 46, 1000, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-018-0553-xDOI Listing
May 2018

De vrais espoirs et de sérieuses préoccupations.

Rev Med Suisse 2018 May;14(607):1011-1012

Genolier Cancer Center, Clinique de Genolier.

View Article

Download full-text PDF

Source
May 2018

Genomic Features of Response to Combination Immunotherapy in Lung Cancer.

Cancer Cell 2018 05;33(5):791-793

Department of Medical Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183017
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.04.005DOI Listing
May 2018

Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors.

J Clin Oncol 2018 10 7;36(30):3007-3014. Epub 2018 May 7.

Jeremy Lewin and Lillian L. Siu, Princess Margaret Cancer Center, Toronto, Ontario, Canada; Jean-Charles Soria and Christophe Massard, Institut Gustave Roussy and University Paris-Sud, Villejuif; Jean-Pierre Delord, Institut Claudius Regaud Oncopole, Toulouse; Mohamed Bekradda, Oncology Therapeutic Development, Clichy; Keyvan Rezai, Hôpital René Huguenin, Saint-Cloud, France; Anastasios Stathis, Oncology Institute of Southern Switzerland, Bellinzona; Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Ahmad Awada and Philippe G. Aftimos, Université Libre de Bruxelles, Brussels, Belgium; and Zhen Zeng, Azher Hussain, and Susan Perez, Merck & Co, Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.2292DOI Listing
October 2018

EML4-ALK Variant Affects ALK Resistance Mutations.

J Clin Oncol 2018 04 1;36(12):1257-1259. Epub 2018 Mar 1.

Martin Früh, Cantonal Hospital of St Gallen, St Gallen, Switzerland; and Solange Peters, University Hospital of Lausanne, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.2764DOI Listing
April 2018

RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung Adenocarcinoma.

J Thorac Oncol 2018 03 6;13(3):387-398. Epub 2017 Dec 6.

Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.11.121DOI Listing
March 2018

PD-1 blockade in advanced NSCLC: A focus on pembrolizumab.

Cancer Treat Rev 2018 Jan 23;62:39-49. Epub 2017 Oct 23.

Department of Oncology, University Hospital Zürich, Rämistrasse 100, 8091 Zürich, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2017.10.002DOI Listing
January 2018

Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer.

N Engl J Med 2017 11;377(20):1986-1988

From Columbia University Medical Center, New York (N.A.R.); and Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (S.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1711430DOI Listing
November 2017

Feasibility of advanced practice nursing in lung cancer consultations during early treatment: A phase II study.

Eur J Oncol Nurs 2017 Aug 12;29:106-114. Epub 2017 Jun 12.

Institute of Higher Education and Research in Healthcare, Faculty of Biology and Medicine, University of Lausanne and Lausanne University Hospital, Switzerland; Department of Oncology, Lausanne University Hospital, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejon.2017.05.007DOI Listing
August 2017

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.

N Engl J Med 2017 06;376(25):2415-2426

From the Ohio State University Comprehensive Cancer Center, Columbus (D.P.C.); LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf (M.R.), and Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.) - both in Germany; Hospital Universitario Doce de Octubre, Centro Nacional de Investigaciones Oncológicas and Universidad Complutense, Madrid (L.P.-A., J.C.J.), Vall d'Hebron University Hospital, Barcelona (E.F.), and Hospital Universitario Insular de Gran Canaria, Las Palmas (D.R.-A.) - all in Spain; H. Lee Moffitt Cancer Center, Tampa, FL (B.C.); Vanderbilt University Medical Center, Nashville (L. Horn); Antoni van Leeuwenhoek Ziekenhuis, Amsterdam (M.M.H.), and University of Groningen, Universitair Medisch Centrum Groningen, Groningen (T.J.N.H.) - both in the Netherlands; Prof. Dr. Ion Chiricuta Institute of Oncology and University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania (T.-E.C.); Baptist Health Lexington, Lexington, KY (F.B.); Duke University, Durham, NC (N.R.); Lehigh Valley Health Network, Allentown (S.N.), Fox Chase Cancer Center, Philadelphia (H.B.), and University of Pittsburgh Medical Center Cancer Center, Pittsburgh (L.C.V., M.A.S.) - all in Pennsylvania; Juravinski Cancer Centre, Hamilton, ON, Canada (R.J.); Oncology Department, Lausanne University Hospital, Lausanne, Switzerland (S.P.); Santa Maria Hospital, Terni, Italy (E.M.); Hollings Cancer Center, Charleston, SC (J.M.W.); Department of Thoracic-Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (G.R.B.); Klinika Pneumologie a Hrudní Chirurgie, Nemocnice Na Bulovce, Prague, Czech Republic (L. Havel, J.K.); and Bristol-Myers Squibb, Princeton, NJ (H.C., W.J.G., P.B., A.C.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1613493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487310PMC
June 2017

L’accès à l’innovation.

Rev Med Suisse 2017 May;13(563):1027

Département d'oncologie, CHUV, Lausanne.

View Article

Download full-text PDF

Source
May 2017

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

J Clin Oncol 2017 Aug 13;35(24):2781-2789. Epub 2017 Jun 13.

Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne; Martin Früh, Kantonsspital St Gallen, St Gallen, Switzerland; Scott Gettinger, Yale Cancer Center, New Haven, CT; Melissa L. Johnson, Sarah Cannon Research Institute, Nashville, TN; Pasi A. Jänne, Dana-Farber Cancer Institute, Boston, MA; Marina C. Garassino, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Daniel Christoph, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany; Chee Keong Toh, National Cancer Centre, Singapore, Singapore; Naiyer A. Rizvi and Jamie E. Chaft, Memorial Sloan Kettering Cancer Center; Jamie E. Chaft, Weill Cornell Medical College, New York, NY; Enric Carcereny Costa, Catalan Institute of Oncology Badalona, Badalona; Luis Paz-Ares, Hospital Universitario Doce de Octubre & IIS i+12, CNIO, Ciberonc and Universidad Complutense, Madrid; Enriqueta Felip, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain; Jyoti D. Patel, University of Chicago, Chicago, IL; Laura Q.M. Chow, University of Washington, Seattle, WA; Marianna Koczywas, City of Hope, Duarte; Zhengrong Li, Jiaheng Qiu, Marcin Kowanetz, Simonetta Mocci, Geetha Shankar, and Alan Sandler, Genentech, South San Francisco, CA; Cheryl Ho, Vancouver Centre, BC Cancer Agency, Vancouver, British Columbia; Jeffrey Rothenstein, R.S. McLaughlin Durham Regional Cancer Centre, Oshawa; Frances A. Shepherd, Princess Margaret Cancer Centre/University Health Network and University of Toronto, Toronto, Ontario, Canada; Michel van den Heuvel, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; and Takayasu Kurata, Kansai Medical University Hirakata Hospital, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562171PMC
August 2017

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2017 08 6;377(9):829-838. Epub 2017 Jun 6.

From Lausanne University Hospital, Lausanne (S.P.), and F. Hoffmann-La Roche, Basel (A.Z., E.M., S. Golding, B.B., J.N.) - both in Switzerland; University of Colorado, Denver (D.R.C.); Massachusetts General Hospital, Boston (A.T.S.); University of Michigan, Ann Arbor (S. Gadgeel); Samsung Medical Center, Sungkyunkwan University School of Medicine (J.S.A.), and Seoul National University Hospital (D.-W.K.) - both in Seoul, South Korea; Chao Family Comprehensive Cancer Center, University of California, Irvine, School of Medicine, Orange (S.-H.I.O.); Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France (M.P.); Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland (R.D.); Catalan Institute of Oncology, Barcelona (R.R.); Roche Innovation Center, New York (P.N.M.); and State Key Laboratory of South China, Chinese University of Hong Kong, Hong Kong (T.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1704795DOI Listing
August 2017

Investigating Barriers in HIV-Testing Oncology Patients: The IBITOP Study, Phase I.

Oncologist 2016 10 20;21(10):1176-1182. Epub 2016 Jul 20.

Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061530PMC
October 2016

Seeking New Approaches to Patients With Small Cell Lung Cancer.

Am Soc Clin Oncol Educ Book 2016 ;35:e477-82

From the Merck Research Laboratories, Rahway, NJ; Department of Oncology, HFR Fribourg, Fribourg, Switzerland; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Winship Cancer Institute of Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_158710DOI Listing
January 2017

The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer.

Cancer Treat Rev 2016 Apr 15;45:139-62. Epub 2016 Mar 15.

Princess Margaret Hospital/University Health Network, 610 University Avenue, Toronto M5G 2M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.03.009DOI Listing
April 2016

Emerging Options After Progression During Crizotinib Therapy.

Authors:
Solange Peters

J Clin Oncol 2016 Mar 28;34(7):643-5. Epub 2015 Dec 28.

Lausanne University Hospital, Lausanne, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.1406DOI Listing
March 2016

[Is prescription of a therapy costing 150,000 CHF reasonable?].

Rev Med Suisse 2015 Oct;11(491):1967-72

View Article

Download full-text PDF

Source
October 2015

BRAF Alterations as Therapeutic Targets in Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Oct;10(10):1396-403

*Service d'oncologie médicale, Département d'oncologie, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; and †Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000644DOI Listing
October 2015